» Articles » PMID: 31382405

Sustained Release of Minor-Groove-Binding Antibiotic Netropsin from Calcium-Coated Groove-Rich DNA Particles

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2019 Aug 7
PMID 31382405
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Control of the release properties of drugs has been considered a key factor in the development of drug delivery systems (DDSs). However, drug delivery has limitations including cytotoxicity, low loading efficiency, and burst release. To overcome these challenges, nano or micro-particles have been suggested as carrier systems to deliver chemical drugs. Herein, nano-sized DNA particles (DNAp) were manufactured to deliver netropsin, which is known to bind to DNA minor grooves. The rationally designed particles with exposed rich minor grooves were prepared by DNAp synthesis via rolling circle amplification (RCA). DNAp could load large quantities of netropsin in its minor grooves. An analytical method was also developed for the quantification of netropsin binding to DNAp by UV-visible spectrometry. Moreover, controlled release of netropsin was achieved by forming a layer of Ca on the DNAp (CaDNAp). As a proof of concept, the sustained release of netropsin by CaDNAp highlights the potential of the DNAp-based delivery approach.

Citing Articles

Rolling Circle Amplification as a Universal Method for the Analysis of a Wide Range of Biological Targets.

Garafutdinov R, Sakhabutdinova A, Gilvanov A, Chemeris A Russ J Bioorg Chem. 2021; 47(6):1172-1189.

PMID: 34931113 PMC: 8675116. DOI: 10.1134/S1068162021060078.


Examining the Effects of Netropsin on the Curvature of DNA A-Tracts Using Electrophoresis.

Miller J, Peters J Molecules. 2021; 26(19).

PMID: 34641414 PMC: 8510488. DOI: 10.3390/molecules26195871.


Synthesis, Biological Activity, and Molecular Dynamics Study of Novel Series of a Trimethoprim Analogs as Multi-Targeted Compounds: Dihydrofolate Reductase (DHFR) Inhibitors and DNA-Binding Agents.

Wrobel A, Baradyn M, Ratkiewicz A, Drozdowska D Int J Mol Sci. 2021; 22(7).

PMID: 33916202 PMC: 8037161. DOI: 10.3390/ijms22073685.


DNA Nanostructures in the Fight Against Infectious Diseases.

Smith D, Keller A Adv Nanobiomed Res. 2021; 1(3):2000049.

PMID: 33615315 PMC: 7883073. DOI: 10.1002/anbr.202000049.


Effective Dispensing Methods for Loading Drugs Only to the Tip of DNA Microneedles.

Bok M, Zhao Z, Hwang S, Kang H, Jeon S, Ko J Pharmaceutics. 2020; 12(10).

PMID: 33050428 PMC: 7599544. DOI: 10.3390/pharmaceutics12100954.


References
1.
Majee S, Dasgupta D, Chakrabarti A . Interaction of the DNA-binding antitumor antibiotics, chromomycin and mithramycin with erythroid spectrin. Eur J Biochem. 1999; 260(3):619-26. DOI: 10.1046/j.1432-1327.1999.00159.x. View

2.
Brana M, Cacho M, Gradillas A, de Pascual-Teresa B, Ramos A . Intercalators as anticancer drugs. Curr Pharm Des. 2001; 7(17):1745-80. DOI: 10.2174/1381612013397113. View

3.
Seeman N . DNA in a material world. Nature. 2003; 421(6921):427-31. DOI: 10.1038/nature01406. View

4.
HERSHEY A, Chase M . Independent functions of viral protein and nucleic acid in growth of bacteriophage. J Gen Physiol. 1952; 36(1):39-56. PMC: 2147348. DOI: 10.1085/jgp.36.1.39. View

5.
Watson J, Crick F . Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature. 1953; 171(4356):737-8. DOI: 10.1038/171737a0. View